Results 81 to 90 of about 4,210,891 (389)

Evaluation of Patient Reported Safety and Efficacy of Cannabis From a Survey of Medical Cannabis Patients in Canada

open access: yesFrontiers in Public Health, 2021
With the medical use of cannabis permitted in Canada since 2001, patients seek to use this botanical drug to treat a range of medical conditions. However, many healthcare practitioners express the need for further scientific evidence around the use of ...
Shaina P. Cahill   +4 more
doaj   +1 more source

Medical Cannabis for the Treatment of Migraine in Adults: A Review of the Evidence

open access: yesFrontiers in Neurology, 2022
Background Medical cannabis (MC) has been hypothesized as an alternative therapy for migraines, given the undesirable side effects of current migraine medications.
B. Okusanya   +4 more
semanticscholar   +1 more source

The Genetic Wiring of Plant Trichomes: From Initiation to Fate Specification

open access: yesAdvanced Science, EarlyView.
Plant trichomes are not just simple hairs but metabolic powerhouses shaped by complex genetic programs. While the MYB‐bHLH‐WD40 module is well studied in Arabidopsis, recent findings reveal that HD‐Zip IV transcription factors drive multicellular and glandular trichome development through dose‐dependent mechanisms.
Meng Li   +3 more
wiley   +1 more source

High-CBD Extract (CBD-X) in Asthma Management: Reducing Th2-Driven Cytokine Secretion and Neutrophil/Eosinophil Activity

open access: yesPharmaceuticals
Background/Objectives: Asthma is a chronic inflammatory disorder of the airways affecting over 10% of the global population. It is characterized by airway inflammation, mucus hypersecretion, and bronchial hyperresponsiveness, driven predominantly by type
Miran Aswad   +5 more
doaj   +1 more source

An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?

open access: yesMedical Cannabis and Cannabinoids, 2020
This paper evaluates current regulatory regimes of medical cannabis using peer-reviewed and grey literature as well as personal communications. Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access
Anne Katrin Schlag
doaj   +1 more source

Assessment of clinical outcomes in patients with fibromyalgia: Analysis from the UK Medical Cannabis Registry

open access: yesBrain and Behavior, 2023
Introduction : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze changes in health‐related quality of life and incidence of adverse events of those prescribed cannabis‐based medicinal products ...
Claire Wang   +10 more
doaj   +1 more source

Exploring medical cannabis use in individuals with a traumatic brain injury

open access: yesExploration of Medicine, 2023
Aim: Traumatic brain injury (TBI) is a common neurological condition, which can present with a wide range of neuropsychological symptoms. Treating this broad spectrum of symptoms represents a significant medical challenge.
Elizabeth N. R. Schjelderup   +8 more
doaj   +1 more source

Drug use in the year after prison [PDF]

open access: yes, 2019
With poor health and widespread drug problems in the U.S. prison population, post-prison drug use provides an important measure of both public health and social integration following incarceration.
Simes, Jessica T., Western, Bruce
core   +1 more source

Medical cannabis use in Thailand after its legalization: a respondent-driven sample survey

open access: yesPeerJ, 2022
Background Many countries now allow the consumption of cannabis or cannabinoids for medical purposes with varying approaches concerning products allowed and the regulatory frameworks prevailing their endowment.
S. Assanangkornchai   +3 more
semanticscholar   +1 more source

“I never realized how hard recovery is.” A quasi‐experimental evaluation of a youth participatory action research project for opioid prevention

open access: yesAmerican Journal of Community Psychology, EarlyView.
Abstract Youth participatory action research (YPAR) has been effectively used for substance use prevention. Yet, YPAR has not been evaluated for opioids, which negatively impact individuals and communities across the United States. The current study evaluated an opioid‐focused YPAR project.
Elizabeth H. Weybright   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy